Research Article

Bell’s palsy following growth hormone therapy in a patient with Prader-Willi syndrome: The first report

Published: February 20, 2018
Genet. Mol. Res. 17(1): gmr16039877 DOI: 10.4238/gmr16039877

Abstract

Prader–Willi syndrome (PWS) is a complex genetic disorder with different manifestations in infancy and childhood including obesity, type 2 diabetes mellitus, mild to moderate intellectual impairment and learning disabilities. In this syndrome, growth hormone therapy improves outcomes. For the first time, here we report a 11-year-old boy with PWS who presented with three episodes of unilateral facial palsy after starting growth hormone therapy.

Download: